NDC 84778-113 - Salkalli
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 84778-113
- Package NDCs from labels
- 84778-113-02, 84778-113-01, 84778-113-03, 84778-113-04
- Manufacturer
- Guangzhou Yixin Cross-border E-commerce Co., Ltd.
- Effective date
- 2025-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Salkalli - Guangzhou Yixin Cross-border E-commerce Co., Ltd. | Guangzhou Yixin Cross-border E-commerce Co., Ltd. | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84778-113-01 | Salkalli | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | 1 | |
| 84778-113-01 | Salkalli | 0.5 mL in 1 KIT | INJECTION, POWDER, LYOPHILIZED, | 0.5 | 1 | |
| 84778-113-02 | Salkalli | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | 1 | |
| 84778-113-02 | Salkalli | 2 in 1 PACKAGE, COMBINATION | INJECTION, POWDER, LYOPHILIZED, | 2 | 1 | |
| 84778-113-03 | Salkalli | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | 1 | |
| 84778-113-03 | Salkalli | 3 in 1 PACKAGE, COMBINATION | INJECTION, POWDER, LYOPHILIZED, | 3 | 1 | |
| 84778-113-04 | Salkalli | 4 in 1 PACKAGE, COMBINATION | INJECTION, POWDER, LYOPHILIZED, | 4 | 1 | |
| 84778-113-04 | Salkalli | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 28152c9f-b15c-3707-e063-6394a90a70e9 | 2025-11-10 | Warnings | 8MDF5V39QO |
| QUABIC-300 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | c3cd7f0f-8d70-23af-e053-2a95a90a569b | 2025-11-10 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Henry Schein, Inc. | da484a2f-154f-48b4-8467-7a86729204c3 | 2025-11-07 | Warnings, Adverse reactions | 8MDF5V39QO |
| 43023cf0-85b2-cbbe-e063-6294a90a76a4 | 43023ce6-c6df-20b6-e063-6294a90ab6ed | 2025-11-07 | Warnings | 43023cf0-85b2-cbbe-e063-6294a90a76a4 43023ce6-c6df-20b6-e063-6294a90ab6ed | ||
| AZO Yeast Plus | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR | i-Health, Inc. | 22845cac-8011-4ea8-b35e-b72973eddb44 | 2025-11-07 | Warnings | 451W47IQ8X |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Henry Schein, Inc. | 2e81ffca-05c6-4fa0-8911-4b3cbfa71351 | 2025-11-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Rising Pharma Holdings, Inc. | 42870188-b1d7-4934-a6c0-310530497dac | 2025-11-07 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | d8b8d796-bfba-42af-a859-99d776871558 | 2025-11-07 | Adverse reactions | 451W47IQ8X |
| Bacteriostatic Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | 31188cdf-7bc8-4d78-bfaf-c1dc9f851fd4 | 2025-11-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea20a5eb-641e-48cd-bcfa-74c04c45dfda | 2025-11-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | d3d29c8f-c326-4097-814a-7f4e08c67068 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | 01721071-af03-4894-95c1-10b8bc64b888 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| CEO-TWO | LAXATIVE | Beutlich Pharmaceuticals, LLC | 08670636-5795-4db0-e063-6294a90afa4b | 2025-11-05 | Warnings | 8MDF5V39QO |
| Dextrose in Lactated Ringers | DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | 190da07e-a616-46e6-b4e5-1c0ba39306e5 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | f6d82772-638c-4584-b9d3-8833669f5963 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Walgreen Company | 8753a131-f8b1-48e1-993b-73c1ee635fef | 2025-11-04 | Warnings | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | CVS Pharmacy | 186732a3-13b9-4ea2-ba54-424f63298a2e | 2025-11-04 | Warnings | 8MDF5V39QO |
| basic care omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Amazon.com Services LLC | 4587f491-04ef-4c31-b7b6-bfafd31776fb | 2025-11-04 | Warnings | 8MDF5V39QO |
| Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, SULPHUR | TRP Company | 42b6b9b9-a673-0bba-e063-6394a90a8866 | 2025-11-03 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.